Source: Anais. Conference titles: Congress of the Brazilian Society for Cell Biology. Unidades: FCF, IQ, FMRP
Subjects: HETEROGENEIDADE, NEOPLASIAS, MELANOMA, BIOMARCADORES
ABNT
CARVALHO, Larissa Anastácio da Costa et al. Tumor heterogeneity and resistance to cancer therapies: peroxiredoxin 1 as a contributor in melanoma. 2021, Anais.. São Paulo: SBBC, 2021. Disponível em: http://www.sbbc.org.br/wp-content/uploads/2014/08/SCIENTIFIC-PROGRAM-CONGRESS_2021.pdf. Acesso em: 28 ago. 2024.APA
Carvalho, L. A. da C., Maria-Engler, S. S., Uehara, A. H., Siena, Á. D. D., Mori, M. P., Souza-Pinto, N. C. de, et al. (2021). Tumor heterogeneity and resistance to cancer therapies: peroxiredoxin 1 as a contributor in melanoma. In Anais. São Paulo: SBBC. Recuperado de http://www.sbbc.org.br/wp-content/uploads/2014/08/SCIENTIFIC-PROGRAM-CONGRESS_2021.pdfNLM
Carvalho LA da C, Maria-Engler SS, Uehara AH, Siena ÁDD, Mori MP, Souza-Pinto NC de, Silva Junior WA da, Smalley K. Tumor heterogeneity and resistance to cancer therapies: peroxiredoxin 1 as a contributor in melanoma [Internet]. Anais. 2021 ;[citado 2024 ago. 28 ] Available from: http://www.sbbc.org.br/wp-content/uploads/2014/08/SCIENTIFIC-PROGRAM-CONGRESS_2021.pdfVancouver
Carvalho LA da C, Maria-Engler SS, Uehara AH, Siena ÁDD, Mori MP, Souza-Pinto NC de, Silva Junior WA da, Smalley K. Tumor heterogeneity and resistance to cancer therapies: peroxiredoxin 1 as a contributor in melanoma [Internet]. Anais. 2021 ;[citado 2024 ago. 28 ] Available from: http://www.sbbc.org.br/wp-content/uploads/2014/08/SCIENTIFIC-PROGRAM-CONGRESS_2021.pdf